Antinociceptive actions of intrathecal xylazine: Interactions with spinal cord opioid pathways

British Journal of Anaesthesia

Volumn 76, Issue 4, 1996, Pages 544-551

  Goodchild, G S ^a,c   Guo, Z ^a   Davies, A ^b   Gent, J P ^b  

^a Department of Anaesthesia ^*  (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Analgesics opioid, fentanyl; Pain, mechanism; Spinal cord; Sympathetic nervous system, adrenergic block; Sympathetic nervous system, xylazine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENTANYL; IDAZOXAN; OPIATE AGONIST; XYLAZINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; INTRATHECAL DRUG ADMINISTRATION; MALE; NECK; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL CORD; TAIL; TAIL FLICK TEST;

EID: 13344259983     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.4.544     Document Type: Article

References (27)

1. Danzebrink RM, Gebhart GF. Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. Journal of Pharmacology and Experimental Therapeutics 1990; 253: 698-705.
2. Sherman S, Loomis C, Milne B, Cervenko F. Prolonged spinal analgesia in the rat with the alpha-adrenoceptor agonist oxymetazoline. European Journal of Pharmacology 1987; 140: 25-32.
3. 2-adrenoceptor subtypes in the spinal cord. European Journal of Pharmacology 1992; 219: 465-468.
4. Takano Y, Yaksh TL. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. Journal of Pharmacology and Experimental Therapeutics 1992; 261: 764-772.
5. Boulter N, Serrao JM, Gent JP, Goodchild CS. Spinally mediated antinociception after intrathecal chlordiazepoxide further evidence for a benzodiazepine spinal analgesic effect. European Journal of Anaesthesiology 1991; 8: 407-411.
6. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 1990; 73: 273-277.
7. Goodchild CS, Sanghera S, Serrao JM, Gent JP. Analgesia mediated by spinal k-opioid receptors. European Journal of Anaesthesiology 1991; 8: 227-231.
8. Goodchild CS, Serrao JM. Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. British Journal of Anaesthesia 1987; 59: 1563-1570.
9. Serrao JM, Stubbs SC, Goodchild CS, Gent JP. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects (published erratum appears in Anesthesiology 1989; 71: 482). Anesthesiology 1989; 70: 780-786.
10. Goodchild CS, Guo Z, Gent JP. Spinally-mediated antinociceptive effects of xylazine, an alpha adrenoceptor agonist: interaction with spinal cord opioid pathways. British Journal of Anaesthesia 1991; 67: 201P.
11. Guo Z, Gent JP, Goodchild CS. Intrathecal 5-hydroxytryptamine produces analgesia by activating spinal cord opioid pathways. Pain 1990; (Suppl 5): S103.
12. Guo Z, Gent JP, Goodchild CS. Two GABA mechanisms for spinally-mediated antinociception: evidence from antagonism of 5-hydroxytryptamine (5HT) by bicuculline. British Journal of Anaesthesia 1990; 64: 589-590P.
13. Sherman SE, Loomis CW, Milne B, Cervenko FW. Tolerance to intrathecal oxymetazoline-induced analgesia, with paradigm-dependent cross-tolerance to intrathecal morphine. Journal of Pharmacology and Experimental Therapeutics 1988; 245: 319-326.
14. Sherman SE, Loomis CW, Milne B, Cervenko FW. Intrathecal oxymetazoline produces analgesia via spinal alpha-adrenoceptors and potentiates spinal morphine (published erratum appears in European Journal of Pharmacology 1988; 154: 345-348). European Journal of Pharmacology 1988; 148: 371-380.
15. Solomon RE, Gebhart GF. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on arterial pressure. Journal of Pharmacology and Experimental Therapeutics 1988; 245: 444-454.
16. Zimmerman M. Ethical guidelines for investigation of experimental pain on conscious animals. Pain 1983; 16: 109-110.
17. Serrao JM, Goodchild CS, Gent JP. Reversal by naloxone of spinal antinociceptive effects of fentanyl, ketocyclazocine, and midazolam. European Journal of Anesthesiology 1991; 8: 401-406.
18. Schmauss C. Spinal kappa-opioid receptor-mediated antino-ciceprion is stimulus-specific. European Journal of Pharmacology 1987; 137: 197-205.
19. Schmauss C, Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. Journal of Pharmacology and Experimental Therapeutics 1984; 228: 1-12.
20. Reddy SV, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. Journal of Pharmacology and Experimental Therapeutics 1980; 213: 525-533.
21. Reddy SV, Yaksh TL. Spinal noradrenergic terminal system mediates antinociception. Brain Research 1980; 189: 391-401.
22. Waterman A, Livingston A, Bouchenafa O. Analgesic effects of intrathecally-applied alpha 2-adrenoceptor agonists in conscious, unrestrained sheep. Neuropharmacology 1988; 27: 213-216.
23. Yaksh TL, Reddy SV. Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology 1981; 54: 451-467.
24. Skingle M, Hayes AG, Tyers MB. Anrinociceptive activity of clonidine in the mouse, rat and dog. Life Sciences 1982; 31: 1123-1132.
25. Stevens CW, Monasky MS, Yaksh TL. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. Journal of Pharmacology and Experimental Therapeutics 1988; 244: 63-70.
26. Shiomi H, Takagi H. Morphine analgesia and the bulbospinal noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics. British Journal of Pharmacology 1974; 52: 519-526.
27. Takagi H, Shiomi H, Kuraishi Y, Fukui K, Ueda H. Pain and the bulbospinal noradrenergic system: pain-induced increase in normetanephrine content in the spinal cord and its modification by morphine. European Journal of Pharmacology 1979; 54: 99-107.